Urgent.News

the world's headlines, one feed

Finance & Markets

Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says

Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.

We haven't written up this one. CNBC World has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at cnbc.com →

More in Finance & Markets